Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
10 Aug, 2026, 03.13 PM IST
Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
10 Aug, 2026, 11.10 AM IST
India's big billion-dollar trade deals are done. Now comes the real testIndia has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...
06 Aug, 2026, 12.33 PM IST
Uzbekistan invites Indian firms for mining, minerals push ahead of PM Modi's visitIn a bid to enhance economic ties, Uzbekistan is inviting Indian investments into its mining and metallurgy sectors, highlighting lucrative...
05 Aug, 2026, 07.02 PM IST
ETMarkets Smart Talk| Large caps offer stability, but alpha lies in selective mid- and small-caps: Rakesh VyasWhile the near-term outlook remains clouded by inflation concerns and margin pressures, Rakesh Vyas, CIO & Portfolio Manager at Quest Inves...
05 Aug, 2026, 08.03 AM IST
Govt weighs PLI 2.0 with sharper focus on high-performing sectorsIndia is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...
05 Aug, 2026, 12.29 AM IST
India's exports from SEZs up 11.8% in 2025-26: GovtExports from special economic zones experienced a remarkable boost in 2025-26, eclipsing USD 185 billion. The pharmaceutical industry also ...
04 Aug, 2026, 03.42 PM IST
Trade deals open new markets for Indian medical device makers, but import risks remain: AiMeDThe EU offers the biggest long-term opportunity for Indian medical device makers, while the UK has more immediate strategic value, says AiM...
04 Aug, 2026, 11.43 AM IST
Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
04 Aug, 2026, 01.04 AM IST
The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
03 Aug, 2026, 12.43 AM IST
India ready for a premium wealth show while US missiles rattle the worldIndia's festive shopping season is set to highlight the country's premiumisation boom despite global uncertainty triggered by the US-Iran w...
01 Aug, 2026, 11.59 AM IST
Sankaran Naren favours banks, power as oil risks loomSankaran Naren, CIO of ICICI Prudential Asset Management, remains bullish on banks, power utilities, oil refiners and pharmaceuticals, citi...
31 Jul, 2026, 10.48 AM IST
Gujarat industry seeks easier access to incentives, lower cost of doing businessIndustry stakeholders say the opportunity for them lies in strengthening the link between its large industrial base and MSMEs while reducin...
29 Jul, 2026, 10.31 AM IST
Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
27 Jul, 2026, 11.07 AM IST
Food products lead PLI job creation, outpace electronics and pharmaFood processing leads PLI employment, creating jobs with minimal investment. Electronics manufacturing attracted significant capital but ge...
22 Jul, 2026, 03.35 PM IST
200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
22 Jul, 2026, 01.13 PM IST
Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
22 Jul, 2026, 12.48 PM IST